clofibric acid has been researched along with Angina at Rest in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Voudris, VA | 1 |
| Skoularigis, JS | 1 |
| Dimitriou, YK | 1 |
| Grapsa, GN | 1 |
| Malakos, JS | 1 |
| Pavlides, GS | 1 |
| Manginas, AN | 1 |
| Cokkinos, DV | 1 |
1 trial available for clofibric acid and Angina at Rest
| Article | Year |
|---|---|
Diabetes mellitus and unstable coronary artery disease: improved clinical outcome of coronary artery stenting in an era of glycoprotein IIb/IIIa inhibitors and lipid-lowering therapy.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Clofibric Acid; Combined Modality Therapy; D | 2004 |